291 related articles for article (PubMed ID: 18487533)
21. Breast-specific gamma imaging: correlations with mammographic and clinicopathologic characteristics of breast cancer.
Park JY; Yi SY; Park HJ; Kim MS; Kwon HJ; Park NH; Moon SY
AJR Am J Roentgenol; 2014 Jul; 203(1):223-8. PubMed ID: 24951219
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer.
Krishnaiah G; Sher-Ahmed A; Ugwu-Dike M; Regan P; Singer J; Totoonchie A; Spiegler E; Sardi A
Breast J; 2003; 9(4):288-94. PubMed ID: 12846862
[TBL] [Abstract][Full Text] [Related]
23. Comparison of breast specific gamma imaging and molecular breast tomosynthesis in breast cancer detection: Evaluation in phantoms.
Gong Z; Williams MB
Med Phys; 2015 Jul; 42(7):4250-9. PubMed ID: 26133623
[TBL] [Abstract][Full Text] [Related]
24. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves.
Buscombe JR; Cwikla JB; Holloway B; Hilson AJ
J Nucl Med; 2001 Jan; 42(1):3-8. PubMed ID: 11197976
[TBL] [Abstract][Full Text] [Related]
25. Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique.
Weigert JM; Bertrand ML; Lanzkowsky L; Stern LH; Kieper DA
AJR Am J Roentgenol; 2012 Jan; 198(1):W69-75. PubMed ID: 22194518
[TBL] [Abstract][Full Text] [Related]
26. Breast-Specific γ-Imaging for the Detection of Mammographically Occult Breast Cancer in Women at Increased Risk.
Brem RF; Ruda RC; Yang JL; Coffey CM; Rapelyea JA
J Nucl Med; 2016 May; 57(5):678-84. PubMed ID: 26823569
[TBL] [Abstract][Full Text] [Related]
27. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast.
Rhodes DJ; O'Connor MK; Phillips SW; Smith RL; Collins DA
Mayo Clin Proc; 2005 Jan; 80(1):24-30. PubMed ID: 15667025
[TBL] [Abstract][Full Text] [Related]
28. Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
Rosen EL; Turkington TG; Soo MS; Baker JA; Coleman RE
Radiology; 2005 Feb; 234(2):527-34. PubMed ID: 15671006
[TBL] [Abstract][Full Text] [Related]
29. Real-world application of breast-specific gamma imaging, initial experience at a community breast center and its potential impact on clinical care.
Zhou M; Johnson N; Blanchard D; Bryn S; Nelson J
Am J Surg; 2008 May; 195(5):631-5; discussion 635. PubMed ID: 18374889
[TBL] [Abstract][Full Text] [Related]
30. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
Khalkhali I; Cutrone JA; Mena IG; Diggles LE; Venegas RJ; Vargas HI; Jackson BL; Khalkhali S; Moss JF; Klein SR
Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855
[TBL] [Abstract][Full Text] [Related]
31. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m sestamibi in the diagnosis of breast cancer. The Mayagüez Medical Center experience.
Farías-Jimenez J; Rivera A; Carlo VM
Bol Asoc Med P R; 2001; 93(1-12):9-11. PubMed ID: 12755069
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of breast-specific gamma imaging (BSGI) for breast cancer in Korea: a comparative study.
Lee A; Chang J; Lim W; Kim BS; Lee JE; Cha ES; Moon BI
Breast J; 2012 Sep; 18(5):453-8. PubMed ID: 22897514
[TBL] [Abstract][Full Text] [Related]
34. Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer?
Cwikla JB; Buscombe JR; Holloway B; Parbhoo SP; Davidson T; McDermott N; Hilson AJ
Nucl Med Commun; 2001 Dec; 22(12):1287-93. PubMed ID: 11711898
[TBL] [Abstract][Full Text] [Related]
35. Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
Tan H; Zhang H; Yang W; Fu Y; Gu Y; Du M; Cheng D; Shi H
Nucl Med Commun; 2016 Aug; 37(8):792-9. PubMed ID: 27058361
[TBL] [Abstract][Full Text] [Related]
36. Gamma Imaging-Guided Minimally Invasive Breast Biopsy: Initial Clinical Experience.
Brem RF; Mehta AK; Rapelyea JA; Akin EA; Bazoberry AM; Velasco CD
AJR Am J Roentgenol; 2018 Mar; 210(3):695-699. PubMed ID: 29323551
[TBL] [Abstract][Full Text] [Related]
37. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Performance of Breast-Specific Gamma Imaging (BSGI) for Breast Cancer: Usefulness of Dual-Phase Imaging with (99m)Tc-sestamibi.
Park JS; Lee AY; Jung KP; Choi SJ; Lee SM; Kyun Bae S
Nucl Med Mol Imaging; 2013 Mar; 47(1):18-26. PubMed ID: 24895504
[TBL] [Abstract][Full Text] [Related]
39. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
Orel SG; Rosen M; Mies C; Schnall MD
Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
[TBL] [Abstract][Full Text] [Related]
40. Breast-specific gamma imaging is a cost effective and efficacious imaging modality when compared with MRI.
Johnson N; Sorenson L; Bennetts L; Winter K; Bryn S; Johnson W; Glissmeyer M; Garreau J; Blanchard D
Am J Surg; 2014 May; 207(5):698-701; discussion 701. PubMed ID: 24791629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
